STAT February 10, 2025
Experts are skeptical of the grand claims of startups like Absci and Generate Biomedicines
It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier.
Absci CEO Sean McClain — tall, with short, gelled hair and a beard, the kind of all-American entrepreneur who mowed lawns to buy...